Research output per year
Research output per year
- 18 results
Search results
-
2024
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions
Blatný, J., Astermark, J., Catarino, C., Dolan, G., Fijnvandraat, K., Hermans, C., Holstein, K., Jiménez-Yuste, V., Klamroth, R., Lavin, M., Lenting, P. J., Lobet, S., Mancuso, M. E., Motwani, J., O’Donnell, J. S. & Königs, C., 2024, In: Therapeutic advances in hematology. 15Research output: Contribution to journal › Review article › peer-review
Open Access -
2023
Koagulationsfaktor XIII – inte bara ett kongenitalt blödningsproblem
Translated title of the contribution :Factor XIII deficiency - not only a congenital bleeding disorder Research output: Contribution to journal › Review article › peer-review
Open Access -
Applicability of the European Society of Cardiology Guidelines on the management of acute coronary syndromes to older people with haemophilia A – A modified Delphi consensus by the ADVANCE Working Group
Klamroth, R., Ay, C., De Moerloose, P., Fontana, P., Windyga, J., Astermark, J., Berntorp, E., Carvalho, M., Dolan, G., Hermans, C., Holme, P. A., Kenet, G., Mancuso, M. E., Marquardt, N., Nunez, R., Pabinger, I., Rodgers, R., Valk, P. V. D., Yuste, V. J. & Zupan, I. P., 2023, In: Haemophilia. 29, 1, p. 21-32Research output: Contribution to journal › Review article › peer-review
-
Considerations for shared decision management in previously untreated patients with hemophilia A or B
Astermark, J., Blatný, J., Königs, C., Hermans, C., Jiménez-Yuste, V. & Hart, D. P., 2023, In: Therapeutic advances in hematology. 14Research output: Contribution to journal › Review article › peer-review
Open Access -
2022
Clinical studies of extended-half-life recombinant FVIII products for prophylaxis in adults and children: A critical review from the physician's perspective
Hermans, C., Reding, M. T., Astermark, J., Klamroth, R. & Mancuso, M. E., 2022 Jun, In: Critical Reviews in Oncology/Hematology. 174, 103678.Research output: Contribution to journal › Review article › peer-review
Open Access -
International consensus recommendations on the management of people with haemophilia B
Hart, D. P., Matino, D., Astermark, J., Dolan, G., d’Oiron, R., Hermans, C., Jiménez-Yuste, V., Linares, A., Matsushita, T., McRae, S., Ozelo, M. C., Platton, S., Stafford, D., Sidonio, R. F. & Tiede, A., 2022 Apr, In: Therapeutic advances in hematology. 13Research output: Contribution to journal › Review article › peer-review
Open Access -
2021
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review
Dolan, G., Astermark, J. & Hermans, C., 2021 May 1, In: Haemophilia. 27, 3, p. e314-e330 17 p.Research output: Contribution to journal › Review article › peer-review
-
2015
FVIII inhibitors: pathogenesis and avoidance.
Astermark, J., 2015, In: Blood. 125, 13, p. 2045-2051Research output: Contribution to journal › Review article › peer-review
-
Genetic risk factors for inhibitors in haemophilia A
Bardi, E. & Astermark, J., 2015, In: European Journal of Haematology. 94, p. 7-10Research output: Contribution to journal › Review article › peer-review
-
Non-genetic risk factors and their influence on the management of patients in the clinic
Alvarez, T., Soto, I. & Astermark, J., 2015, In: European Journal of Haematology. 94, p. 2-6Research output: Contribution to journal › Review article › peer-review
-
Strategies for reducing inhibitor formation in severe haemophilia
Tunstall, O. & Astermark, J., 2015, In: European Journal of Haematology. 94, p. 45-50Research output: Contribution to journal › Review article › peer-review
-
2014
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
Laros-van Gorkom, B. A. P., Falaise, C. & Astermark, J., 2014, In: European Journal of Haematology. 93, p. 26-38Research output: Contribution to journal › Review article › peer-review
-
Managing Haemophilia for Life: 4th Haemophilia Global Summit
Astermark, J., Dolan, G., Hilberg, T., Jimenez-Yuste, V., Laffan, M., Lassila, R., Lobet, S., Martinoli, C. & Perno, C.-F., 2014, In: Haemophilia. 20, p. 1-20Research output: Contribution to journal › Review article › peer-review
-
2012
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Gouw, S. C., van den Berg, H. M., Oldenburg, J., Astermark, J., de Groot, P. G., Margaglione, M., Thompson, A. R., van Heerde, W., Boekhorst, J., Miller, C. H., le Cessie, S. & van der Bom, J. G., 2012, In: Blood. 119, 12, p. 2922-2934Research output: Contribution to journal › Review article › peer-review
-
2010
Clinical issues in inhibitors
Astermark, J., Santagostino, E. & Hoots, W. K., 2010, In: Haemophilia. 16, p. 54-60Research output: Contribution to journal › Review article › peer-review
-
Von Willebrands sjukdom--från biokemi till klinisk praxis.
Translated title of the contribution :Von Willebrand disease--from biochemistry to clinical practice Research output: Contribution to journal › Review article › peer-review
-
2008
From theory to practice: Applying current clinical knowledge and treatment strategies to the care of hemophilia A patients with inhibitors
Gomperts, E. D., Astermark, J., Gringeri, A. & Teitel, J., 2008, In: Blood Reviews. 22, Suppl 1, p. S1-S11Research output: Contribution to journal › Review article › peer-review
-
1998
The Malmo-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts
Berntorp, E., Astermark, J., Jurgutis, R., Lethagen, S. & Petersson, C., 1998, In: Haemophilia. 4, 2, p. 79-82Research output: Contribution to journal › Review article › peer-review